PA-22-176, SBIR, Phase I, Novel Bispecific Nanotherapeutics as Broad-Spectrum Influenza Antivirals Refractory to Viral Escape
-
Award Number: R43IP001224
-
ORGANIZATION: NATIONAL CENTER FOR ZOONOTIC, VECTOR-BORNE, AND ENTERIC DISEASES
-
OPDIV: CDC
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
-
PERIOD OF PERFORMANCE START DATE: 09/30/2023
-
PERIOD OF PERFORMANCE END DATE: 03/29/2025